Emergent Biosolutions Inc (0IGA)
LSE
Emergent BioSolutions Finalizes Sale of Travel Health Business to Bavarian Nordic GAITHERSBURG, Md., May 15, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced it...
Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 Million GAITHERSBURG, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 51.6 | 51.6 | 51.6 | 5197 | 51.6 | DE |
4 | 0 | 0 | 51.6 | 51.6 | 51.6 | 4484 | 51.6 | DE |
12 | 0 | 0 | 51.6 | 51.6 | 51.6 | 8517 | 51.6 | DE |
26 | 0 | 0 | 51.6 | 51.6 | 51.6 | 21940 | 51.6 | DE |
52 | 0 | 0 | 51.6 | 51.6 | 51.6 | 20713 | 51.6 | DE |
156 | 0 | 0 | 51.6 | 51.6 | 51.6 | 7407 | 51.6 | DE |
260 | 0 | 0 | 51.6 | 51.6 | 51.6 | 4488 | 51.6 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約